FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
- 1 October 2007
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 74 (5) , 307-316
- https://doi.org/10.1016/j.brainresbull.2007.06.023
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The Immunopathology of Multiple Sclerosis: An OverviewBrain Pathology, 2007
- T-Cell-Mediated Disruption of the Neuronal Microtubule Network: Correlation with Early Reversible Axonal Dysfunction in Acute Experimental Autoimmune EncephalomyelitisThe American Journal of Pathology, 2006
- Physiologically Based Pharmacokinetic Modeling of FTY720 (2-Amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in Rats After Oral and Intravenous DosesDrug Metabolism and Disposition, 2006
- Pulmonary and vascular pharmacology of sphingosine 1-phosphateCurrent Opinion in Pharmacology, 2006
- Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal studyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosisTrends in Molecular Medicine, 2006
- Functional hyperemic response in the rat visual cortex under halothane anesthesiaNeuroscience Letters, 2006
- CHEMOKINES, SPHINGOSINE-1-PHOSPHATE, AND CELL MIGRATION IN SECONDARY LYMPHOID ORGANSAnnual Review of Immunology, 2005
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate ReceptorsJournal of Biological Chemistry, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002